Clinical Research News
-
Daiichi Sankyo- AstraZeneca’s breast cancer drug reveals positive response
Clinical Research | News | 0 Comment | 08 May, 2019
Daiichi Sankyo Company, Limited (Daiichi Sankyo) and AstraZeneca have announced positive topline results for the pivotal...Read more
-
Innovent Biologics, Eli Lilly has announced that IBI301 has met pre-defined primary endpoints
Clinical Research | News | 0 Comment | 08 May, 2019
Innovent Biologics and Eli Lilly and Company has jointly announced that IBI301, a recombinant human-mouse...Read more
-
VolitionRx initiates clinical trial programme in lung cancer
Clinical Research | News | 0 Comment | 08 May, 2019
US based VolitionRx Limited has announced that it has added to its extensive clinical trial programme with the execution...Read more
-
Clinical research is becoming more disintegrated with the influx of data from different sources
Clinical Research | Opinion | 0 Comment | 07 May, 2019
Asia Pacific is expected to become the destination of choice for clinical trials due to its fast-growing pharmaceutical ...Read more
-
Clinical Research | News | 0 Comment | 03 May, 2019
Tessa Therapeutics, a clinical-stage cell therapy company focused on autologous and allogeneic therapies for a wide rang...Read more
-
NMPA approves Sinovant's clinical trial application for Derazantinib
Clinical Research | News | 0 Comment | 30 Apr, 2019
Sinovant Sciences has announced that its Clinical Trial Application (CTA) for derazantinib has been accepted by the...Read more
-
ACADIA Pharma initiates Ph3 CLARITY Program with Pimavanserin for MDD
Clinical Research | News | 0 Comment | 26 Apr, 2019
ACADIA Pharmaceuticals, a biopharmaceutical company focused on the development and commercialization of innovative ...Read more
-
CMD LLC wins AU$1 million grant award from FightMND
Clinical Research | News | 0 Comment | 18 Apr, 2019
Collaborative Medicinal Development LLC (CMD) is a privately-held biopharmaceutical company developing innovative therap...Read more
-
Zydus Cadila announces phase III trial of Desidustat
Clinical Research | News | 0 Comment | 17 Apr, 2019
Zydus Cadila, an innovation-driven, global pharmaceutical company, announced the Phase III trials of Desidustat, an Inve...Read more
-
CStone Pharmaceuticals announces dosing in Ph III trial for treating adenocarcinoma
Clinical Research | News | 0 Comment | 16 Apr, 2019
CStone Pharmaceuticals has announced that the first patient has been successfully enrolled and dosed in Phase III clinic...Read more
-
CStone receives IND approval in China for avapritinib study
Clinical Research | News | 0 Comment | 15 Apr, 2019
CStone Pharmaceuticals has announced that the National Medical Products Administration (NMPA) recently approved the init...Read more
-
I-Mab Biopharma collaborates with Roche for combination therapy
Clinical Research | News | 0 Comment | 11 Apr, 2019
I-Mab Biopharma (I-Mab), a clinical stage biopharmaceutical company exclusively focused on the development of potential ...Read more
-
George Clinical establishes new presence in Singapore
Clinical Research | News | 0 Comment | 10 Apr, 2019
George Clinical, a global scientifically backed clinical research organization, (CRO) has expanded its footprint in ...Read more
-
NIH begins first-in-human trial of a universal influenza vaccine candidate
Clinical Research | News | 0 Comment | 05 Apr, 2019
The first clinical trial of an innovative universal influenza vaccine candidate is examining the vaccine’s safety ...Read more
-
Veeda Clinical Research Achieves ISO 27001:2013 Certification
Clinical Research | News | 0 Comment | 03 Apr, 2019
India's leading independent CRO, Veeda Clinical Research Pvt. Ltd. has announced that Bureau Veritas has award...Read more
-
Veeda Clinical Research successfully completes third inspection by NPRA
Clinical Research | News | 0 Comment | 27 Mar, 2019
Veeda Clinical Research Pvt. Ltd., a leading independent CRO has announced that its clinical (Shivalik, Ahmedabad) and B...Read more
-
Eisai starts Phase III clinical trial for Alzheimer's drug
Clinical Research | News | 0 Comment | 25 Mar, 2019
Eisai Co., Ltd. has announced that a global Phase III clinical study (Clarity AD/Study 301) of BAN2401, an anti-amyloid ...Read more
-
WCG introduces a transformational solution for clinical research sites
Clinical Research | News | 0 Comment | 20 Mar, 2019
WIRB-Copernicus Group has introduced WCG SiteReady, a first-of-its-kind solution aimed at increasing the efficiency and ...Read more
